Clinical Trials Directory

Trials / Completed

CompletedNCT00150436

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.

An Open-Label Extension Safety and Efficacy Study of Pregabalin in Patients With Postherpetic Neuralgia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
276 (planned)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate long-term safety and efficacy of pregabalin in patients with postherpetic neuralgia.

Conditions

Interventions

TypeNameDescription
DRUGPregabalin

Timeline

Start date
2002-02-01
Completion
2005-07-01
First posted
2005-09-08
Last updated
2006-12-22

Source: ClinicalTrials.gov record NCT00150436. Inclusion in this directory is not an endorsement.

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. (NCT00150436) · Clinical Trials Directory